Oncotech, Inc. Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Oncotech is a biotechnology research company based in Tustin, California. It provides molecular oncology testing services to more than a thousand hospitals across the United States and Europe, supporting physicians in the care and management of cancer patients. The company also conducts genomic research aimed at quickly identifying new cancer diagnostics and therapeutics. Within the oncology Diagnostics field, it emphasizes in vitro drug resistance and therapy selection testing. The organization is small to mid-sized and has a history of acquisition, having been purchased in 2008 by Exiqon A/S, which later became part of Qiagen, situating it within a broader network of established life sciences players.